Evaluation of the relationship between preeclampsia and positive rectovaginal culture of group B Streptococcus and Helicobacter pylori positive serology
- 4 October 2021
- journal article
- research article
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11 (1)
Abstract
Introduction: Identifying the incidence of pathogen colonizations in pregnant women with preeclampsia can be effective in providing proper treatment and reducing complications. Objectives: We evaluated the frequency and association between positive rectovaginal culture of group B Streptococcus (GBS) and positive Helicobacter pylori serology with preeclampsia in two groups of pregnant women (with and without preeclampsia). Patients and Methods: The present case-control study included pregnant women with preeclampsia and healthy pregnant controls during 2019-2020. Blood and rectovaginal samples were obtained and the data were statistically analyzed using SPSS software. Results: Fifty-four people were included in the study. The mean gestational age was 36 ± 3.4 months in the preeclampsia group and 37 ± 2.9 months in the control group. There was no significant relationship between preeclampsia and H. pylori-positive serology (P=0.84). Additionally, the association between positive H. pylori serology and the severity of preeclampsia was not significant (P=0.15). However, there was a significant relationship between positive H. pylori tests with early- and late-onset preeclampsia (P=0.04). However, there was no statistically significant relationship between the positive rectovaginal culture of GBS and preeclampsia, the severity of preeclampsia, the onset time, or the weight of newborns. Conclusion: There was a significant relationship between H. pylori infection and late-onset preeclampsia in preeclamptic mothers. H. pylori screening and eradication therapy before pregnancy can prevent preeclampsia and its serious consequences in both the mother and the fetus.Keywords
This publication has 18 references indexed in Scilit:
- Pre-eclampsiaThe Lancet, 2021
- Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and ChinaJAMA Network Open, 2021
- Preeclampsia: Pathophysiology and managementJournal of Gynecology Obstetrics and Human Reproduction, 2021
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisGastroenterology, 2017
- Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidencesHelicobacter, 2016
- Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studiesBMJ, 2016
- Pathogenesis of Helicobacter pylori InfectionHelicobacter, 2015
- If we know so much about preeclampsia, why haven’t we cured the disease?Journal of Reproductive Immunology, 2013
- Group B streptococcal colonization and the risk of pre-eclampsiaEpidemiology and Infection, 2012
- Genotype of the CYBA promoter −930A/G, polymorphism C677T of the MTHFR and APOE genotype in patients with hypertensive disorders of pregnancy: An observational studyMedicina Clinica, 2009